ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Brooklyn ImmunoTherapeutics Inc

Brooklyn ImmunoTherapeutics Inc (BTX)

9.79
0.00
(0.00%)
Closed December 26 4:00PM
0.00
0.00
(0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 000051k17k47k47k
Operating Income -14.29M1.25M-5.32M-4.6M-5.51M-5.77M-5.79M-4.93M
Pre Tax Income -7.31M-4.45M-5.41M-4.5M-5.6M-6.16M-6.64M-5.53M
Net Income -7.32M-4.5M-5.42M-4.52M-5.59M-6.16M-6.65M-5.54M
Preferred Dividends 0-8k0-8k0-8k0-8k
Basic Earnings Per Share (EPS) 00000000
EBIT -14.29M1.33M-5.37M-4.83M-5.51M-5.82M-5.79M-4.93M
EBITDA -14.25M1.27M-5.3M-4.58M-5.49M-5.74M-5.75M-4.89M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 22.31M21.27M23.34M19.81M5.8M0068k
Operating Income -2.28M-1.4M203k-1.76M-6.31M-113.73M-27.23M-21.14M
Pre Tax Income -2.89M-1.01M-323k-2.02M-4.42M-122.3M-24.53M-21.67M
Net Income -2.92M-1.08M-275k-2.06M-4.43M-122.32M-24.6M-21.68M
Preferred Dividends 00-16k-16k-16k-16k-16k-16k
Basic Earnings Per Share (EPS) -1.214-0.402-0.091-0.677-1.419-2.344-4.655-3.896
EBIT -2.31M-513k66k-1.77M-4.28M-122.3M-28.4M-21.47M
EBITDA 609k915k3.25M1.67M-3.46M-113.73M-27.07M-21.05M